IDEXX Laboratories, Inc. (IDXX) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

IDEXX Laboratories, Inc. (IDXX) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

IDXX

Market Closed

IDEXX Laboratories, Inc.

NASDAQHealthcare Medical - Diagnostics & Research

11.00K employees

CEO: Jonathan J. Mazelsky

Founded: 1991

$562.09

+$0.00(+NaN%)

Market Cap

44.34B

Beta

1.54

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: IDEXX's current price exceeds all valuation methods' midpoints, with a PERT fair value 24.7% lower, indicating overvaluation risk. Monte Carlo analysis shows a wide value range with 100% downside risk scenarios below the current price, reflecting high volatility. Strong profitability and growth contrast with liquidity and leverage rated moderate.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore IDXX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples